Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
Roswell Park Cancer Institute
University of California, San Diego
Incyte Corporation
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Massachusetts General Hospital
Thomas Jefferson University
M.D. Anderson Cancer Center
Columbia University
Thomas Jefferson University
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Gilead Sciences
Fred Hutchinson Cancer Center
Takeda
Columbia University
Pfizer
GlaxoSmithKline
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Molecular Templates, Inc.
Emory University
Kiadis Pharma
Dana-Farber Cancer Institute
Genenta Science
Terumo BCTbio
Kiadis Pharma
Menarini Group
Novartis
Pfizer
M.D. Anderson Cancer Center
NYU Langone Health
Gilead Sciences
University of Illinois at Chicago
Novartis
Novartis
Incyte Corporation
Fate Therapeutics
Medical University of South Carolina
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dartmouth-Hitchcock Medical Center
St. Jude Children's Research Hospital